Finance

Lists
Why is NBP down 10,09%?
Dive Deeper
NBP:NASDAQ
NovaBridge Biosciences
0,91 US$
-10,09%
(-0,10) 1D
0,91 US$
+0,10% (+0,00090)
After hours
Closed: 5 ნოე, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NBP...
Open
1,01 US$
High
1,04 US$
Low
0,90 US$
Mkt. cap
106,90 მლნ.
Avg. vol.
654,70 ათ.
Volume
939,97 ათ.
52-wk high
5,17 US$
52-wk low
0,90 US$
EPS
-0,66 US$
Beta
1,71
Shares outstanding
115,65 მლნ.
No. of employees
30
Open
1,01 US$
High
1,04 US$
Low
0,90 US$
Mkt. cap
106,90 მლნ.
Avg. vol.
654,70 ათ.
Volume
939,97 ათ.
52-wk high
5,17 US$
52-wk low
0,90 US$
EPS
-0,66 US$
Beta
1,71
Shares outstanding
115,65 მლნ.
No. of employees
30
News stories
From web sources and news partners
About NovaBridge Biosciences
CEO-
Employees30
Founded2014
Headquartersროკვილი, მერილენდი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitenovabridge.com
Analyst ratings
Based on 1 analyst giving stock ratings to NBP in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NBP in the last 3 months
Highest
Current 0,91 US$
9,00 US$ (+891,08%)
Average
9,00 US$ (+891,08%)
Lowest
9,00 US$ (+891,08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
9,00 US$
+891,1%
10/30/2026
Justin Zelin
BTIG
Buy
Reiterated
9,00 US$
+891,1%
01/06/2026
Daina Graybosch
Leerink Partners
Buy
Initiated
9,00 US$
+891,1%
10/06/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3,18 მლნ.
55,66 მლნ.
7,16 მლნ.
7,16 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,81 მლნ.
17,24 მლნ.
13,21 მლნ.
13,21 მლნ.
Operating expense
8,99 მლნ.
72,90 მლნ.
20,37 მლნ.
20,37 მლნ.
Total operating expenses
8,99 მლნ.
72,90 მლნ.
20,37 მლნ.
20,37 მლნ.
Operating income
-8,99 მლნ.
-72,90 მლნ.
-20,37 მლნ.
-20,37 მლნ.
Other non operating income
31,00 ათ.
-11,00 ათ.
20,50 ათ.
20,50 ათ.
EBT including unusual items
-6,83 მლნ.
-72,86 მლნ.
-18,93 მლნ.
-18,93 მლნ.
EBT excluding unusual items
-6,81 მლნ.
-71,12 მლნ.
-19,10 მლნ.
-19,10 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-6,83 მლნ.
-72,86 მლნ.
-18,93 მლნ.
-18,93 მლნ.
Net profit margin
-
-
-
-
Earnings per share
-0,06
-0,31
-
-
Interest and investment income
2,15 მლნ.
1,79 მლნ.
1,17 მლნ.
1,17 მლნ.
Interest expense
-
-
-
-
Net interest expenses
2,15 მლნ.
1,79 მლნ.
1,17 მლნ.
1,17 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-8,97 მლნ.
-72,88 მლნ.
-20,34 მლნ.
-20,34 მლნ.
Gain or loss from assets sale
-
-
14,00 ათ.
14,00 ათ.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები